331 related articles for article (PubMed ID: 33455353)
1. Applications of Two-Dimensional Nanomaterials in Breast Cancer Theranostics.
Mohammadpour Z; Majidzadeh-A K
ACS Biomater Sci Eng; 2020 Apr; 6(4):1852-1873. PubMed ID: 33455353
[TBL] [Abstract][Full Text] [Related]
2. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
3. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
[TBL] [Abstract][Full Text] [Related]
4. Two-dimensional nanomaterials for tumor microenvironment modulation and anticancer therapy.
Wu M; Niu X; Zhang R; Ping Xu Z
Adv Drug Deliv Rev; 2022 Aug; 187():114360. PubMed ID: 35636568
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances of Emerging Metal-Containing Two-Dimensional Nanomaterials in Tumor Theranostics.
Li C; Fang X; Zhang H; Zhang B
Int J Nanomedicine; 2024; 19():805-824. PubMed ID: 38283201
[TBL] [Abstract][Full Text] [Related]
6. Graphene-like Metal-Free 2D Nanosheets for Cancer Imaging and Theranostics.
Luo Y; Li Z; Zhu C; Cai X; Qu L; Du D; Lin Y
Trends Biotechnol; 2018 Nov; 36(11):1145-1156. PubMed ID: 29954613
[TBL] [Abstract][Full Text] [Related]
7. Two-Dimensional Nanomaterials for Cancer Nanotheranostics.
Chen Y; Wu Y; Sun B; Liu S; Liu H
Small; 2017 Mar; 13(10):. PubMed ID: 28075057
[TBL] [Abstract][Full Text] [Related]
8. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
[TBL] [Abstract][Full Text] [Related]
9. Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
Rabaan AA; Bukhamsin R; AlSaihati H; Alshamrani SA; AlSihati J; Al-Afghani HM; Alsubki RA; Abuzaid AA; Al-Abdulhadi S; Aldawood Y; Alsaleh AA; Alhashem YN; Almatouq JA; Emran TB; Al-Ahmed SH; Nainu F; Mohapatra RK
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557793
[TBL] [Abstract][Full Text] [Related]
10. Application and Future Prospect of Extracellular Matrix Targeted Nanomaterials in Tumor Theranostics.
Fang W; Su D; Lu W; Wang N; Mao R; Chen Y; Ge K; Shen A; Hu R
Curr Drug Targets; 2021; 22(8):913-921. PubMed ID: 33504304
[TBL] [Abstract][Full Text] [Related]
11. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
[TBL] [Abstract][Full Text] [Related]
12. Bioactive inorganic nanomaterials for cancer theranostics.
Pei Z; Lei H; Cheng L
Chem Soc Rev; 2023 Mar; 52(6):2031-2081. PubMed ID: 36633202
[TBL] [Abstract][Full Text] [Related]
13. Inorganic nanomaterials with rapid clearance for biomedical applications.
Wang X; Zhong X; Li J; Liu Z; Cheng L
Chem Soc Rev; 2021 Aug; 50(15):8669-8742. PubMed ID: 34156040
[TBL] [Abstract][Full Text] [Related]
14. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
Ma Y; Huang J; Song S; Chen H; Zhang Z
Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
[TBL] [Abstract][Full Text] [Related]
17. Physically-triggered nanosystems based on two-dimensional materials for cancer theranostics.
Ji DK; Ménard-Moyon C; Bianco A
Adv Drug Deliv Rev; 2019 Jan; 138():211-232. PubMed ID: 30172925
[TBL] [Abstract][Full Text] [Related]
18. Recent advancements in two-dimensional nanomaterials for drug delivery.
Mei X; Hu T; Wang Y; Weng X; Liang R; Wei M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1596. PubMed ID: 31650709
[TBL] [Abstract][Full Text] [Related]
19. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
[TBL] [Abstract][Full Text] [Related]
20. A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials.
Gupta N; Rai DB; Jangid AK; Kulhari H
Curr Drug Metab; 2019; 20(6):506-532. PubMed ID: 30251600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]